SEARCH

SEARCH BY CITATION

References

  • BISOGNO, T., HANUS, L., DE PETROCELLIS, L., TCHILIBON, S., PONDE, D.E., BRANDI, I., MORIELLO, A.S., DAVIS, J.B., MECHOULAM, R. & DI MARZO, V. (2001). Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br. J. Pharmacol., 134, 845852.
  • CARLISLE, S.J., MARCIANO-CABRAL, F., STAAB, A., LUDWICK, C. & CABRAL, G.A. (2002). Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation. Int. Immunopharmacol., 2, 6982.
  • GUZMAN, M. (2003). Cannabinoids: potential anticancer agents. Nat. Rev. Cancer, 3, 745755.
  • HOWLETT, A.C., BARTH, F., BONNER, T.I., CABRAL, G., CASELLAS, P., DEVANE, W.A., FELDER, C.C., HERKENHAM, M., MACKIE, K., MARTIN, B.R., MECHOULAM, R. & PERTWEE, R.G. (2002). International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev., 54, 161202.
  • JARAI, Z., WAGNER, J.A., VARGA, K., LAKE, K.D., COMPTON, D.R., MARTIN, B.R., ZIMMER, A.M., BONNER, T.I., BUCKLEY, N.E., MEZEY, E., RAZDAN, R.K., ZIMMER, A. & KUNOS, G. (1999). Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc. Natl. Acad. Sci. U.S.A., 96, 1413614141.
  • JORDÀ, M.A., VERBAKEL, S.E., VALK, P.J., VANKAN-BERKHOUDT, Y.V., MACCARRONE, M., FINAZZI-AGRO, A., LOWENBERG, B. & DELWEL, R. (2002). Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol. Blood, 99, 27862793.
  • JOSEPH, J., NIGGEMANN, B., ZAENKER, K.S. & ENTSCHLADEN, F. (2004). Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes. Cancer Immunol. Immunother., 1853, 723728.
  • KISHIMOTO, S., GOKOH, M., OKA, S., MURAMATSU, M., KAJIWARA, T., WAKU, K. & SUGIURA, T. (2003). 2-Arachidonoylglycerol induces the migration of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes through the cannabinoid CB2 receptor-dependent mechanism. J. Biol. Chem., 278, 2446924475.
  • MASSI, P., VACCANI, A., CERUTI, S., COLOMBO, A., ABBRACCHIO, M.P. & PAROLARO, D. (2004). Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines. J. Pharmacol. Exp. Ther., 308, 838845.
  • PAROLARO, D., MASSI, P., RUBINO, T. & MONTI, E. (2002). Endocannabinoids in the immune system and cancer. Prostaglandins Leukot. Essent. Fatty Acids, 66, 319332.
  • PERTWEE, R.G. & ROSS, R.A. (2002). Cannabinoid receptors and their ligands. Prostaglandins Leukot. Essent. Fatty Acids, 66, 101121.
  • PORTELLA, G., LAEZZA, C., LACCETTI, P., DE PETROCELLIS, L., DI MARZO, V. & BIFULCO, M. (2003). Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis. FASEB J., 17, 17711773 (Epub 2003 Jul 03).
  • ROTH, M.D., BALDWIN, G.C. & TASHKIN, D.P. (2002). Effects of delta-9-tetrahydrocannabinol on human immune function and host defense. Chem. Phys. Lipids, 121, 229239.
  • SACERDOTE, P., MASSI, P., PANERAI, A.E. & PAROLARO, D. (2000). In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors. J. Neuroimmunol., 109, 155163.
  • SANCHEZ, C., GALVE-ROPERH, I., CANOVA, C., BRACHET, P. & GUZMAN, M. (1998). Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Lett., 436, 610.
  • SONG, C. & HOWLETT, A.C. (1995). Rat brain cannabinoid receptors are N-linked glycosylated proteins. Life Sci., 56, 19831989.
  • WALTER, L., FRANKLIN, A., WITTING, A., WADE, C., XIE, Y., KUNOS, G., MACKIE, K. & STELLA, N. (2003). Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J. Neurosci., 23, 13981405.